Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
9
Bearish filings
1
Named actors
4
Disclosed $ (bull / bear)
$80.0M + 1 of unknown size / size unknown
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-09-25 | Activist (13D) ORBIMED ADVISORS LLC | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-09-21 | Director ORBIMED ADVISORS LLC | bought | $5.0M | SEC ↗ |
| 2026-09-21 | Director OrbiMed Genesis GP LLC | bought | $5.0M | SEC ↗ |
| 2026-09-21 | Director OrbiMed Capital GP VII LLC | bought | $5.0M | SEC ↗ |
| 2026-09-21 | Director OrbiMed Genesis GP LLC | bought | $15.0M | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-09-21 | Director OrbiMed Capital GP VII LLC | bought | $15.0M | SEC ↗ |
| 2026-09-21 | Director ORBIMED ADVISORS LLC | bought | $15.0M | SEC ↗ |
| 2026-09-21 | Director GORDON CARL L | bought | $5.0M | SEC ↗ |
| 2026-09-21 | Director GORDON CARL L | bought | $15.0M | SEC ↗ |
| 2026-09-18 | Issuer (share issuance) | priced an offering | — | SEC ↗ |